Myelodysplastic Syndromes, High Risk: Clinical Trials

2 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Recruiting 2
Phase 2	2	Recruiting 2

Follow Myelodysplastic Syndromes, High Risk: new trials by email Literature Review of Myelodysplastic Syndromes, High Risk trials Research Report on Myelodysplastic Syndromes, High Risk

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Sonrotoclax Plus Azacitidine in Patients With MDS-IB2 Sonrotoclax, Azacitidine (AZA) - Myelodysplastic Syndromes, High Risk	Phase 1 / Phase 2	Recruiting	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	60	2026-10-15	2026-10-21
A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. ECT-001-CB - Acute Leukemia, High Risk, Myelodysplastic Syndromes, High Risk	Phase 1 / Phase 2	Recruiting	Ciusss de L'Est de l'Île de Montréal	7	2025-10-06	2025-12-24

Narrower conditions

Myelodysplastic Syndromes (2)

Broader conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)

Interventions

Azacitidine (1)

Sponsors

Ciusss de L'Est de l'Île de Montréal (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

Canada (1)  ·  China (1)

Top investigators

Sandra Cohen, Dr. (1)